|
Post by falconquest on Jul 24, 2020 12:35:08 GMT -5
Medallion Therapeutics, Inc., another AMF company founded by Alfred E Mann, recently completed trials of "an innovative infusion pump which will provide totally accurate delivery of prescribed drugs to people suffering from chronic illnesses such as diabetes and neurodegenerative diseases." "According to a spokesperson from Medallion Therapeutics the development of the infusion pump by the team at AMF comes after more than 10 years of research and development to create the novel Medallion implantable drug delivery system. "Announcing the formation of Medallion Therapeutics David Hankin, Chief Executive Officer of the Alfred Mann Foundation, remarked that the new infusion pump holds considerable promise of providing patients and physicians with a superior method of infusion therapy than what is currently available on the market I do find that interesting! I also found it interesting that the "artificial pancreas" gets a relatively fast approval by he FDA, and while watching ABC news this morning, they announce the pump, show photos of it, etc. The very next day after approval, major media exposure! The contrast of the path that AFREZZA has had to take has been very different, to say the least. Just an observation... GLTA TRUE LONGS! Can you please provide me a link to the Medallion study? I looked at their website but didn't find anything. Thanks!
|
|